D. Gjaltema

E-mail:
d.gjaltema rug.nl

Research

Postal address:
A Deusinglaan1
Gebouw 3213, ruimte 0218
9713 AV
Groningen
Netherlands
Phone: +31 50 363 2399Fax: +31 50 363 2500
Publications
  1. Comparison of the in vitro performance of originator and generic drug-combination dry powder inhalers

    Teekamp, N., Hagedoorn, P., Huijbers, B. G., Gjaltema, D., Frijlink, H. W. & De Boer, A. H., 1-Sep-2013, In : European Respiratory Journal. 42

    Research output: Contribution to journalMeeting AbstractAcademic

  2. Comparative in vitro performance of the new drug aclidinium in a novel multidose dry powder inhaler

    Gjaltema, D., Hagedoorn, P., Grasmeijer, F., Huijbers, B. G., Frijlink, H. W. & De Boer, A. H., 1-Sep-2013, In : European Respiratory Journal. 42

    Research output: Contribution to journalMeeting AbstractAcademic

  3. Are extra-fine particles from dry powder inhalers likely to improve lung deposition?

    Gjaltema, D., Hagedoorn, P., Frijlink, H. W. & De Boer, A. H., 1-Sep-2014, In : European Respiratory Journal. 44

    Research output: Contribution to journalMeeting AbstractAcademic

  4. Can 'extrafine' dry powder aerosols improve lung deposition?

    De Boer, A. H., Gjaltema, D., Hagedoorn, P. & Frijlink, H. W., Oct-2015, In : European Journal of Pharmaceutics and Biopharmaceutics. 96, p. 143-151 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (24) »

ID: 75444